Prestige Consumer Healthcare Inc. (PBH): Price and Financial Metrics

Prestige Consumer Healthcare Inc. (PBH)

Today's Latest Price: $36.67 USD

0.30 (0.82%)

Updated Nov 27 5:00pm

Add PBH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

PBH Stock Summary

  • For PBH, its debt to operating expenses ratio is greater than that reported by 85.45% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, Prestige Consumer Healthcare Inc is reporting a growth rate of 372.71%; that's higher than 96.06% of US stocks.
  • In terms of volatility of its share price, PBH is more volatile than merely 4.52% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Prestige Consumer Healthcare Inc, a group of peers worth examining would be COOP, ARCO, IDCC, VIRT, and OSN.
  • Visit PBH's SEC page to see the company's official filings. To visit the company's web site, go to

PBH Stock Price Chart Interactive Chart >

Price chart for PBH

PBH Price/Volume Stats

Current price $36.67 52-week high $46.12
Prev. close $36.37 52-week low $27.40
Day low $35.88 Volume 126,392
Day high $36.80 Avg. volume 450,340
50-day MA $35.30 Dividend yield N/A
200-day MA $37.56 Market Cap 1.84B

Prestige Consumer Healthcare Inc. (PBH) Company Bio

Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.

PBH Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$36.67$61.97 72%

Below please find a table outlining a discounted cash flow forecast for PBH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Prestige Consumer Healthcare Inc ranked in the 59th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for PBH, they are:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 54. Notably, its equity weight is greater than just 13.34% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 46% of the company's capital is sourced from debt; this is greater than 72.72% of the free cash flow producing stocks we're observing.
  • Prestige Consumer Healthcare Inc's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 8.66% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Prestige Consumer Healthcare Inc? See DGX, JAZZ, CAH, HCSG, and ANIP.

PBH Latest News Stream

Event/Time News Detail
Loading, please wait...

PBH Latest Social Stream

Loading social stream, please wait...

View Full PBH Social Stream

Latest PBH News From Around the Web

Below are the latest news stories about Prestige Consumer Healthcare Inc that investors may wish to consider to help them evaluate PBH as an investment opportunity.

Prestige Consumer Healthcare (PBH) - Investor Presentation - Slideshow

The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 25, 2020

Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q1 2021 Results - Earnings Call Transcript

Prestige Consumer Healthcare Inc. (PBH) Q1 2021 Earnings Conference Call August 6, 2020 08:30 AM ET Company Participants Phil Terpolilli - Director, IR Ron Lombardi - Chairman, President and CEO Christine Sacco - CFO Conference Call Participants Steph Wissink - Jefferies Rupesh Parikh - Oppenheimer Linda Weiser - D.A. Davidson...

SA Transcripts on Seeking Alpha | August 9, 2020

Registration - Sidoti's 2020 Fall Virtual Investor Conference is Open Now.

Our Biannual Investor Conference has become a leading forum for small-cap companies to interface with investors specifically interested in the small-cap equities.

Yahoo | July 31, 2020

Prestige Brands (PBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results

TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first…

GlobeNewswire | July 13, 2020

Read More 'PBH' Stories Here

PBH Price Returns

1-mo 11.02%
3-mo 0.66%
6-mo -9.34%
1-year -2.91%
3-year -17.85%
5-year -29.31%
YTD -9.46%
2019 31.15%
2018 -29.59%
2017 -14.76%
2016 1.20%
2015 48.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8973 seconds.